Skip to content
Screener

Scholar Rock SRRK Net margin

Discontinued — last reported Q1 '22

Net margin at other companies

Biogen logo
BiogenBIIB
8.8%-6.5pp
PTC Therapeutics logo
PTC TherapeuticsPTCT
42.3%+27.4pp
CalAmp logo
CalAmpCAMP
-2,193.7%-581pp
Wave Life Sciences logo
Wave Life SciencesWVE
-66.5%-29.9pp

Other financials

Income statement

See full
Revenue-—
Operating income-$108.9M+2.9%
Net income-$109.9M+0.1%
EPS (diluted)-$0.84+14.3%

Balance sheet

See full
Cash & equivalents$437.1M+186%
Total debt$203.8M+231%
Total equity$253.8M+8.8%
Total assets$523.5M+54.0%

Cash flow

See full
Operating cash flow-$70.3M+8.6%
CapEx$1.0K-99.5%
Free cash flow-$70.3M+8.9%

Valuation

See full
Market cap$6.41B+92.7%
Enterprise value$6.18B+90.9%

Profitability

See full
Operating margin-231.8%—
FCF margin-309.1%—

Returns & leverage

See full
Return on equity-167.8%-4.1pp
Debt / equity0.8×+0.5×
Current ratio7×+0.7×

Where this comes from

Calculated from Scholar Rock’s reported figures.

net income/total revenue=-236.9%

Based on trailing twelve months.

The source filing: Scholar Rock’s 10-Q, filed May 9, 2023. Open the filing →

Filed
May 9, 2023
Fiscal quarter
Q1 FY2023
Calendar quarter
Q1 2023
Accession
0001558370-23-008674

FAQ

What is Scholar Rock's net margin?
Scholar Rock (SRRK) reported net margin of -236.9% in Q1 2022.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Scholar Rock's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude